Kimberly-Clark swoops on Tylenol maker Kenvue as deal spree accelerates

$49bn tie-up came on frantic day of mergers and acquisitions across corporate America

Read More

BTC miner IREN lands $9.7B Microsoft deal, accelerating industry pivot to GPUs

IREN’s Microsoft partnership underscores how Bitcoin miners are reinventing themselves as AI infrastructure providers amid tightening margins.

Read More

Pfizer files second lawsuit to block Novo Nordisk’s $9bn Metsera deal

Suit alleges merger would violate competition laws in market for weight-loss drugs

Read More

Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings, Outlook

Idexx stock gains after Q3 earnings and revenue beat expectations, driven by strong CAG growth and raised 2025 earnings and sales guidance. Latest Ratings for IDXX DateFirmActionFromTo Feb 2022Atlantic EquitiesInitiates Coverage OnOverweight Nov 2021Morgan StanleyInitiates Coverage OnOverweight Aug 2021Credit SuisseMaintainsOutperform View More Analyst Ratings for IDXX …

Read More

Bitcoin price hits $111K November high but bear market fears persist

Bitcoin traders doubted the staying power of last-minute weekend BTC price upside as selling pressure from whales returned into the weekly close.

Read More

Bitcoin Tops $100K Despite ETF Outflows, Analysts Warn of Rising Volatility, Here’s What’s Next for Investors

Bitcoin's (CRYPTO: BTC) price hit the $100,000 mark in the early hours of Saturday, despite experiencing its worst performance since 2018 with a 3.7% decline as October concluded. This milestone comes amidst an increase in volatility and outflows from Bitcoin ETFs. read more

Read More

Teradyne, Wayfair, And Illumina Are Among the Top 10 Large-Cap Gainers Last Week (Oct. 27-Oct. 31): Are the Others in Your Portfolio?

Top weekly large-cap gainers included Teradyne, Wayfair, Illumina, Guardant Health, ASE, C.H. Robinson, Lumen, Symbotic, Credo, YPF after strong results. read more

Read More

‘I Might Get Wiped Out’: Chilling Messages Show Charlie Kirk’s Fear Years Before His Killing

read more

Read More

Charlie Munger Once Explained Why He And Warren Buffett Refuse To Short Stocks — And It Started With Latter’s Tendency To Invest In ‘Lousy Companies’

Charlie Munger once explained that he and Warren Buffett refused to short stocks because they found it unpleasant and unproductive — a lesson rooted in Buffett's early experience buying "lousy companies" and later reinforced by the duo's shift toward owning high-quality, brand-driven businesses like See's Candies and Coca-Cola. read more

Read More

Berkshire Hathaway offloads $6.1bn of stock

Cash reserves at conglomerate hit record as Warren Buffett prepares for retirement

Read More

 
BUILT ON A CARBON NEUTRAL BLOCKCHAIN NETWORK

© MegaHoot, LLC. All Rights Reserved  |  media at hootdex.com  Privacy Policy  |  Risk Disclosure  |  Legal Disclaimer  |  TOS  | Neutrality  |  AML/KYC

error: Content is protected !!